Close Menu

CHICAGO (GenomeWeb) – When Biden Cancer Initiative President Greg Simon speaks in public, his attention-grabbing line is also an eye-opener.

"The cancer is the only part of the system that's completely focused on the patient," Simon said during the opening keynote of the annual American Medical Informatics Association (AMIA) informatics summit in late March.

That quip was meant to illustrate the myriad factors working against each cancer patient receiving the most appropriate care possible.

Get the full story with
Premium Access

Only $95 for the
first 90 days*

Premium Access gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try Premium Access now.

You may already have institutional access!

Check if I qualify.

Already a Precision Oncology News or 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Dec
02
Sponsored by
Qiagen

The Phosphoinositide 3-Kinase (PI3K) pathway is one of the most frequently altered pathways in human cancer and plays a significant role in disease progression and resistance to endocrine therapy.